Cite
MLA Citation
J. Yao et al.. “5LBA Everolimus in advanced nonfunctional neuroendocrine tumors (NET) of lung or gastrointestinal (GI) origin: Efficacy and safety results from the placebo-controlled, double-blind, multicenter, Phase 3 RADIANT-4 study.” European journal of cancer, vol. 51, n.d., pp. S709–S710. http://access.bl.uk/ark:/81055/vdc_100030687872.0x000057